Article

Corneal implant applications expand to include keratoconus

Washington, DC-Micro-thin prescription inserts (Intacs, Addition Technology), which received FDA approval in the United States in 1999 for the treatment of mild myopia, are an alternative to tissue-ablating laser vision procedures and have a number of advantages.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) EyeCon 2025: Oluwatosin U. Smith, MD, previews a program of collaborative care and practical learning
Related Content
Using opioids to prevent sneezing and potential ocular tissue damage during sedation and periocular injections
August 24th 2025

Using opioids to prevent sneezing and potential ocular tissue damage during sedation and periocular injections

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
August 24th 2025

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

(Image credit: Ophthalmology Times) From firsts to the future: A pioneer's perspective on ophthalmology
August 24th 2025

From firsts to the future: A pioneer's perspective on ophthalmology

Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures
August 24th 2025

(EyePod) From idea to impact: Navigating ophthalmic innovation

(Image credit: AdobeStock/ipopba) Robotic precision: Elevating the state of laser cataract surgery
August 24th 2025

Robotic precision: Elevating the state of laser cataract surgery

(Image credit: AdobeStock/zabhie) AI applications in cataract surgery: A surgeon’s perspective
August 24th 2025

AI applications in cataract surgery: A surgeon’s perspective

© 2025 MJH Life Sciences

All rights reserved.